Germany's Neovii Biotech GmbH and India's VINS Bioproducts Ltd. will collaborate on manufacturing and commercializing immunoglobulin products.
The collaboration includes anti-thymocyte globulin, used in organ transplantation and treating blood disorders, with technology transfer to India.
The agreement was facilitated by the Embassy of India in Berlin on October 13, 2026, during the Indo-German Health Leadership Dialogue.